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Acute lung injury in the rat caused by intravenous (i.v.) infusion of cobra venom factor (CVF) or lipopolysaccharide (LPS) is mediated
by P-selectin-dependent neutrophil infiltration into the lung. In these lung injury models, P-selectin expression is induced on lung vascular
endothelial cells after the CVF or LPS infusion, suggesting soluble P-selectin derived from inflamed sites might also be elevated. Here we
established a sensitive enzyme-linked immunosorbent assay (ELISA) to measure soluble P-selectin in plasma, a potential marker of lung
injury. Nine anti-rat P-selectin monoclonal antibodies that we established previously were first classified into 5 groups based on real-time
biospecific interaction analyses, and used to develop a sandwich ELISA for accurately measuring the amount of soluble P-selectin in plasma.
We then used this ELISA to measure the plasma P-selectin levels in Long Evans, Wistar, and Sprague–Dawley rats after the i.v. infusion of
CVF or LPS. The elevation in P-selectin levels was significantly different among the strains, but it consistently correlated with the extent of
lung inflammation, measured by myeloperoxidase levels in the lung tissues. Thus, our results indicate that the soluble P-selectin in plasma
could serve as a sensitive biomarker reflecting lung inflammation, which is of clinical importance for detecting and preventing severe lung
injury.
© 2006 Elsevier B.V. All rights reserved.Keywords: P-selectin; Lung injury; ELISA; Monoclonal antibody; Plasma1. Introduction
P-selectin (CD62P) is a member of the selectin family and is
localized to platelet granule membranes and the Weibel–Palade
bodies of endothelial cells. It is expressed on the cell surface
upon cell activation and is the first point of contact for
leukocytes adhering to activated platelets in thrombi or to
activated endothelial cells, where it enables leukocyte rolling,
thereby initiating the adhesion cascade.
Soluble P-selectin lacking the cytosolic/transmembrane
domain has been identified in plasma. It is derived both from
the secretion of an alternatively spliced protein that lacks the
transmembrane domain and from proteolytic cleavage of the
membrane form; thus, it reflects the activation state of platelets⁎ Corresponding author. Tel.: +81 54 264 5710; fax: +81 54 264 5715.
E-mail address: kawashih@u-shizuoka-ken.ac.jp (H. Kawashima).
0925-4439/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2006.11.010and/or endothelial cells. The soluble form of P-selectin is
detected as a circulating protein in plasma from healthy
individuals [1,2], and it is an established marker of platelet
activation [3,4]. High levels of this circulating protein are
associated with several inflammatory and thrombotic disorders
in humans, including diabetes [5], malaria [6], hepatitis [7],
hypertension [8], atherosclerosis, and ischemic heart disease
[9–11].
The expression of P-selectin on endothelial cells of the lung
is up-regulated in rat models of lung injury induced by cobra
venom factor (CVF) [12] or lipopolysaccharides (LPS) [13].
However, how much the soluble P-selectin level in plasma
increases during lung injury remains unknown.
In the present study, we developed a sensitive P-selectin
ELISA, and used it to measure the soluble P-selectin levels in
the plasma of rats with acute lung injury induced by CVF or
LPS. Our results indicate that soluble P-selectin could serve as a
sensitive biomarker to measure the extent of lung injury.
383M. Hirose et al. / Biochimica et Biophysica Acta 1772 (2007) 382–3892. Materials and methods
2.1. Antibodies
The rat P-selectin-human IgG1 fusion protein (P-selectin-IgG) and the
hamster monoclonal antibodies (mAbs) 118, 136, 137, A109, A116, A123,
A216, C104, and C215 against rat P-selectin were previously described [14].
The polyclonal antibody against rat P-selectin was obtained from BD
Biosciences Pharmingen.
2.2. Immunoprecipitation analysis
Thrombin-activated rat platelets were prepared as described previously
[14]. Rat platelets were activated with 3 U/ml thrombin (Sigma-Aldrich, St.
Louis, MO, USA) for 10 min at 37 °C, then washed with PBS and surface-
labeled with 5 ml of 50 μg/ml sulfo-NHS-LC-biotin (Pierce Biotechnology,
Inc., Rockford, IL, USA) for 60 min at 4 °C. The platelets were lysed and pre-
cleared three times for 30 min at 4 °C using 100 μl of protein G-Sepharose
(GE Healthcare Bio-Sciences Corp., Piscataway, NJ, USA). The pre-cleared
lysates were then incubated with 10 μg of anti-P-selectin mAbs and 10 μl of
protein G-Sepharose beads, and the immunoprecipitates were washed and
analyzed by sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). After electrophoresis, the proteins were transferred to an Immobilon-P
membrane and probed with streptavidin–horseradish peroxidase (SA-HRP,
Sigma-Aldrich). After 60 min, the membrane was developed using ECL
Western blotting detection reagents (PerkinElmer Life Sciences, Boston, MA,
USA).
2.3. Purification of rat P-selectin
Anti-rat P-selectin mAb A116, purified by Protein G-Sepharose, was
coupled to 1 ml HiTrap NHS-activated-Sepharose (GE Healthcare Bio-
Sciences Corp.) according to the manufacturer's instructions. The thrombin-
activated rat platelets were lysed with 1% NP-40 in PBS. The sample was
spun at 100,000×g for 30 min, and the supernatant was pre-cleared with
protein G-Sepharose. The supernatant was then applied to the mAb A116-
Sepharose column at 4 °C. After washing the column, the bound fraction was
eluted with 0.1 M glycine–HCl, pH 2.7, and neutralized immediately after
elution. The bound rat P-selectin fraction was separated by SDS-PAGE and
visualized by silver staining.
2.4. Lung injury model
Specific pathogen-free, adult (5–6 weeks old), male Wistar, Sprague–
Dawley, and Long Evans rats were used. Twenty units of CVF (Sigma-Aldrich)/kg
body weight, or 3 mg LPS (Sigma-Aldrich)/kg body weight diluted in saline, or
saline alone was injected intravenously (i.v.) as a bolus infusion [15]. At 30 min
after the administration of CVF, or 4, 24, 48, or 72 h after the administration of
LPS, whole blood was obtained from each rat and mixed with sodium citrate. At
the same time, rat lungs were also collected and stored at −80 °C until use. The
protocols used for all the animal experiments in this study were approved by the
Animal Research Committee of Osaka University.
2.5. Preparation of the sensor chip for BIAcore analysis
The BIAcore system and reagents for interaction analysis were obtained
from BIAcore AB, Uppsala, Sweden. Rat P-selectin derived from platelets was
immobilized on the sensor chip via primary amine groups according to standard
procedures [16,17]. In brief, the immobilization run was performed in HBS, pH
7.4, (10 mM HEPES, 150 mM NaCl, 3.4 mM EDTA, 0.05% surfactant P20).
The carboxylated matrix of the sensor chip was activated with 30 μl of an EDC/
NHS (N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide hydrochloride/N-
hydroxysuccinimide) mixture. Immobilization of rat P-selectin was performed
with 70 μl of 10 μg/ml P-selectin in 100 mM acetate buffer, pH 4.5, and injected
at a flow rate of 10 μl/min. Unreacted groups were blocked by injecting 70 μl of
ethanolamine–HCl, pH 8.5, at 10 μl/min.2.6. Epitope mapping using BIAcore
Binding of the anti-rat P-selectin mAbs to the rat P-selectin-immobilized
sensor chip described above was detected at a constant flow rate of 10 μl/ml of
PBS containing 0.05% Tween-20 in the BIAcore system. A 30-μl aliquot of
primary mAb (diluted to 200 μg/ml in PBS containing 0.05% Tween-20) was
injected over the rat P-selectin surface. The secondary mAb was then injected in
sequence. The sensor chip surface was regenerated with 10 mM glycine–HCl,
pH 2.2 (15 μl).
2.7. Sandwich ELISA
To detect soluble rat P-selectin, a sandwich ELISA using two anti-rat P-
selectin mAbs or a combination of one mAb and the anti-rat P-selectin
polyclonal antibody were performed. Either one anti-rat P-selectin mAb or the
anti-rat P-selectin polyclonal antibody was diluted to 10 μg/ml in PBS and
incubated for 2 h in each well of a 96-well microtiter plate (Sumilon MS-
8596F; Sumitomo Bakelite Co., Tokyo, Japan) at room temperature (RT). The
wells were washed with PBS and blocked with 3% BSA in PBS (3% BSA-
PBS) overnight at 4 °C. The wells were then washed with PBS containing
0.1% BSA and 0.05% Tween-20 (BT-PBS) and incubated with 3, 1, 0.3, 0.1,
0.03, 0.01 or 0 μg/ml rat P-selectin-IgG, rat P-selectin derived from platelets,
or rat plasma P-selectin diluted with PBS containing 0.1% BSA, 0.05%
Tween-20, and 10 mM EDTA, for 2 h at RT. The wells were washed with BT-
PBS, 2 μg/ml biotin-conjugated anti-rat P-selectin mAb was added, and the
plates were incubated for 1 h at RT. The plates were washed with BT-PBS, and
then peroxidase-conjugated streptavidin (1:500, Zymed Laboratories, Inc.,
South San Francisco, CA, USA) was added and the plates were incubated for
60 min at RT. After another wash with BT-PBS, 50 μl per well of o-
phenylenediamine (0.4 mg/ml) in 50 mM sodium citrate, 100 mM Na2HPO4,
pH 5.6 containing 0.012% H2O2 was added, and the chromogenic reaction
was processed for 2 min at room temperature. After the reaction, 8 N H2SO4
was added to each well, and the plate was read at 490 nm in a microtiter plate
reader (InterMed Co., Tokyo, Japan).
2.8. Tissue myeloperoxidase activity
Myeloperoxidase (MPO) activity was measured to assess the influx of
neutrophils into the lung. Lysates from casein-elicited rat peritoneal neutrophils
were used as a control. Lung samples were homogenized using 2 ml
homogenization buffer (PBS containing 1 mM phenylmethanesulfonyl fluoride,
7.2 μM pepstatin A, 10 μM leupeptin, and 1% NP-40) and incubated for 4 h at
4 °C. The mixture was then spun for 20 min at 25,000×g to remove insoluble
materials. The protein concentration of the lysates was adjusted, and the MPO
activity was assayed by measuring the change in absorbance (490 nm) using
H2O2 and o-phenylenediamine as described above.
2.9. Bronchoalveolar Lavage (BAL)
BAL was performed with 10 ml cold PBS. The BAL fluid was centrifuged
and the supernatant aliquoted and stored at −80 °C until further analysis.
Levels of TNF (tumor necrosis factor)-α and IL (interleukin)-1β in the BAL
fluid were determined using an ELISA kit (R&D Systems Europe, Ltd.,
Abingdon, UK). Spectrophotometric measurement of samples and standards
were carried out in duplicate using a microplate reader (Bio-Rad Lab.,
Hercules, CA, USA). Results were recorded as optical densities, plotted
against the linear portion of the standard curve, and expressed as picograms
cytokine per ml of BAL fluid.
2.10. Lung histology
Histopathologic changes induced by LPS were evaluated in three rats.
Briefly, saline-treated rats or LPS-treated rats were prepared as described above.
The lungs were gently infiltrated with 1% low melting point agarose (Nacalai
Tesque, Inc., Kyoto, Japan) at 42 °C through the trachea. Lungs were then
removed en bloc, and fixed in 4% paraformaldehyde, 0.23 M sucrose solution
overnight. The sample was then incubated in 20% sucrose/PBS for 12 h, and then
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sections were stained with hematoxylin–eosin (Wako Chemicals, Osaka, Japan).
2.11. Statistical analysis
Student's t-test was used for statistical analysis. The correlations between P-
selectin concentration andMPO activity were examined using Pearson's product
moment correlation coefficient.
3. Results
3.1. Immunoprecipitation and purification of rat P-selectin
We previously established nine hybridoma cell lines
secreting anti-rat P-selectin mAb [14]. To develop an ELISA
system, it was necessary to determine if the antibodies could
immunoprecipitate rat P-selectin. Three of the anti-rat P-
selectin antibodies, A109, A116, and A216, specifically
immunoprecipitated a protein appearing as a single band of
approximately 130 kDa, which corresponds to the molecular
size of rat P-selectin, from thrombin-activated rat platelets (Fig.
1A). The anti-rat P-selectin mAb C215 immunoprecipitated the
same protein, but its affinity for rat P-selectin seemed lower
than that of mAbs A109, A116, or A216; only a faint band
could be detected with mAb C215. Based on these results, we
prepared a HiTrap NHS-activated Sepharose column coupled
with mAb A116, and used it to purify rat P-selectin from
lysates of thrombin-stimulated platelets. This rat P-selectin had
a purity of more than 95% (Fig. 1B) and a recovery of about
10 μg/rat.Fig. 1. Immunoprecipitation and purification of rat P-selectin with anti-P-
selectin mAb. (A) Immunoprecipitation of P-selectin from rat platelets using
mAbs. Rat thrombin-activated platelets were surface-biotinylated and immuno-
precipitated with the mAbs (lane 1, 118; lane 2, 136; lane 3, 137; lane 4, A109;
lane 5, A116; lane 6, A123; lane 7, A216; lane 8, C104; lane 9, C215) or hamster
IgG (lane 10). Samples were run on SDS-PAGE 8% gels under reducing
conditions and blotted onto a PVDFmembrane. The membrane was treated with
SA-HRP and the bands were detected with ECL. (B) Affinity purification of rat
P-selectin with an anti-P-selectin mAb A116-Sepharose column. Purified rat P-
selectin was run on an SDS-PAGE 8% gel under reducing conditions, and the
band was visualized by silver staining.3.2. Classification of anti-rat P-selectin mAbs into 5 epitope
groups
Real-time biospecific interaction analysis (BIAcore), which
is based on changes in surface plasmon resonance, was used to
classify the epitopes of the nine anti-rat P-selectin mAbs [14].
Examples of sensorgrams for assessing the antibody competi-
tion are shown in Fig. 2A. Sensorgram c indicates that the two
antibodies tested had distinct epitopes, whereas sensorgram d
indicates that the two antibodies tested had overlapping
epitopes. The reactivity patterns of the mAbs determined as
described above are shown in a 9×9 matrix table (Fig. 2B). For
example, the epitopes of mAbs C215 and A109 were different,
since pre-occupation of the P-selectin-immobilized sensor chip
with mAb C215 failed to affect the binding of mAb A109, and
vice versa. In contrast, the epitopes of mAbs 136 and 137 were
overlapping, since each of these mAbs interfered with the
ability of the other to bind its epitope on the sensor chip. Based
on these results, the nine anti-rat P-selectin mAbs were
classified into five groups as follows: group 1 (mAbs 118,
136, 137), group 2 (mAbs A109, A116, A216), group 3 (mAb
C215), group 4 (mAb A123), and group 5 (mAb C104).
3.3. Detection of soluble rat P-selectin by ELISA
P-selectin is rapidly expressed on activated platelets and
endothelial cells and then shed from the cell surface or taken up
by endocytosis [18,19].We hypothesized that circulating soluble
P-selectin might be elevated during inflammation and reflect the
extent of lung injury. We first attempted to develop a sandwich
ELISA using two mAbs that efficiently immunoprecipitated
soluble rat P-selectin, but we could not detect P-selectin using
any combinations of mAbs A109, A116, and A216 (data not
shown), probably because these mAbs fall into the same epitope
group. We therefore performed sandwich ELISAs using
combinations of the anti-rat P-selectin polyclonal antibody and
one of the nine anti-rat P-selectin mAbs (Fig. 3A). Rat P-selectin
derived from platelets or rat P-selectin-IgG was added to wells
coated with the anti-rat P-selectin polyclonal antibody. The wells
were then incubated with biotinylated anti-rat P-selectin mAb
118, 136, 137, A109, A116, A123, A216, C104, or C215. When
the biotinylated A109, A116, or A216 mAb was used, native rat
P-selectin derived from platelets was detected. However, when
the other biotinylated mAbs were used, only recombinant rat P-
selectin-IgG but not native rat P-selectin was detected. In the
ELISA performed with the anti-rat P-selectin polyclonal anti-
body and biotinylated A116 mAb, the detection limit was about
80 ng/ml P-selectin (Fig. 3B).
3.4. Circulating soluble P-selectin levels increase in acute lung
injury
We next measured the levels of soluble P-selectin in vivo
using the CVF model. In this model, lung injury is caused by a
massive infiltration of neutrophils, a process in which P-selectin
plays a major role. To induce acute lung injury, the CVF was
infused into the rats intravenously (i.v.). Lung and plasma
Fig. 2. Epitope groups defined by competitive inhibition studies. (A) Representative sensorgrams obtained from competitive binding experiments by BIAcore. The
second mAb was applied to a sensor chip pre-saturated with the first mAb, as described in Materials and methods. When the epitopes recognized by the two mAbs were
the same or different, a sensorgram resembling d or c, respectively, was obtained after application of the second antibody. Schematic representations of the binding of
mAbs to the sensor chip at various points (a to d) are shown below the sensorgram. (B) Reactivity pattern matrix obtained from a competitive binding experiment by
BIAcore. The resonance units obtained after the second mAb application minus those after the first mAb application were calculated and are shown as symbols: >1000
resonance units (++), 300 to 999 resonance units (+), and <300 resonance units (−).
385M. Hirose et al. / Biochimica et Biophysica Acta 1772 (2007) 382–389samples were collected 30 min after the i.v. infusion, and the
MPO activity and the soluble P-selectin concentration were
measured, respectively (Table 1).MPO is a myeloid cell-specific
peroxidase, and its activity reflects the neutrophil content in the
lung. As shown in Table 1, after the i.v. infusion of CVF, the
MPO activity increased to a level above the control values
obtained after the infusion of saline, indicating that neutrophilinfiltration was induced by the CVF infusion. Table 1 also shows
that the circulating P-selectin values in Long Evens rats was
about six times higher than those in the other rat strains in this
acute lung injury model. Importantly, the soluble P-selectin
levels detected by the sandwich ELISA correlated with the level
of MPO activity in the lung, indicating that soluble P-selectin
levels reflect the severity of the inflammation in the lung.
Table 1
Elevation of plasma P-selectin levels in CVF-treated rats
P-selectin level MPO activity
(OD 490 nm) a (ng/ml) b (OD 490 nm) c
Normal Wistar rat 1 0.081±0.009 n.d. d 0.013±0.003
Normal Wistar rat 2 0.080±0.005 n.d. 0.103±0.005
Normal Wistar rat 3 0.068±0.005 n.d. 0.121±0.005
Normal SD rat 1 0.075±0.004 n.d. 0.125±0.005
Normal SD rat 2 0.091±0.003 n.d. 0.075±0.003
Normal Long Evans rat 1 0.070±0.007 n.d. 0.043±0.005
Normal Long Evans rat 2 0.072±0.004 n.d. 0.065±0.003
Saline Wistar rat 1 0.071±0.007 n.d. 0.163±0.005
Saline Wistar rat 2 0.071±0.006 n.d. 0.195±0.003
Saline Wistar rat 3 0.067±0.008 n.d. 0.113±0.005
Saline Wistar rat 4 0.067±0.003 n.d. 0.120±0.005
Saline SD rat 1 0.077±0.005 n.d. 0.162±0.004
Saline SD rat 2 0.069±0.003 n.d. 0.155±0.005
Saline SD rat 3 0.081±0.003 n.d. 0.192±0.003
Saline Long Evans rat 1 0.087±0.009 n.d. 0.183±0.005
Saline Long Evans rat 2 0.057±0.005 n.d. 0.173±0.005
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LPS. After i.v. infusion of LPS, plasma and lung samples were
collected at 4, 24, 48, and 72 h, and the soluble P-selectin
concentration and MPO activity were measured. As shown in
Fig. 4A and B, the circulating P-selectin in the SD rats was
elevated to two-to three-fold higher than in Wistar rats, and this
elevation correlated with the MPO activity. The coefficients of
correlation between P-selectin concentration and MPO activity
for SD and Wistar rats (from 0 to 24 h) were r=0.996 and
r=0.859, respectively (Fig. 4C). Hematoxylin–eosin staining of
the lung tissues indicated that a large number of leukocytes
accumulated in the parenchyma as well as in the alveolar space
of the LPS-treated Wistar rats, and, to a larger extent, in the
same sites of the LPS-treated SD rats (Fig. 4D to G). As shown
in Table 2, total protein concentration in the BAL fluid 4 h after
LPS administration in SD rats was higher than that in Wistar
rats, indicating that permeability of lung epithelial barrier
increased more significantly in SD rats than in Wistar rats. InFig. 3. Detection of the soluble form of rat P-selectin by sandwich ELISA. (A)
Rat P-selectin-IgG or rat platelet P-selectin was added to anti-rat P-selectin
polyclonal antibody-coated wells. The captured antigen was detected with
biotinylated 118, 136, 137, A109, A116, A123, A216, C104, and C215 mAbs.
Data are expressed as means±SD of triplicate determinations. *, P<0.05,
versus hamster IgG control. (B) Standard curve of rat platelet P-selectin by
sandwich ELISA using a combination of anti-rat P-selectin polyclonal antibody
and biotinylated A116 mAb. Coefficient of correlation, r=0.993.
CVF Wistar rat 1 0.155±0.021 110 0.583±0.014
CVF Wistar rat 2 0.132±0.015 100 0.326±0.052
CVF Wistar rat 3 0.121±0.013 90 0.412±0.032
CVF SD rat 1 0.221±0.017 220 0.529±0.047
CVF SD rat 2 0.184±0.023 190 0.519±0.012
CVF SD rat 2 0.193±0.018 200 0.413±0.038
CVF Long Evans rat 1 0.895±0.006 850 0.883±0.034
CVF Long Evans rat 2 0.822±0.020 790 0.792±0.072
CVF Long Evans rat 3 0.781±0.011 700 0.724±0.067
a OD 490 nm was determined by the sandwich ELISA using the anti-P-
selectin polyclonal antibody and biotinylated A116 as described in Materials
and methods.
b Plasma P-selectin concentration (ng/ml) was determined by the standard
curve shown in Fig. 3B.
c MPO activity (OD 490 nm) in the lung was determined as described in
Materials and methods.
d n.d.: Not detectable.addition, concentrations of TNF-α and IL-1β, proinflammatory
cytokines, in the BAL fluid, also increased more significantly in
SD rats.
4. Discussion
We have developed an ELISA system to measure soluble P-
selectin in the rat. We previously established nine anti-rat P-
selectin mAbs that bind to thrombin-stimulated platelets [14].
Among these mAbs, A109, A116, A216, and C215 could
immunoprecipitate P-selectin from platelets, and the others
could not (Fig. 1 and Table 1). The A109, A116, and
A216 mAbs also worked well in an ELISA for detecting native
P-selectin from platelets, and the other mAbs did not, although
they could detect recombinant P-selectin-IgG chimeric protein
(Fig. 3). These results are probably attributable to differences in
the immunogens. A109, A116, A123, and A216 were
established by immunizing hamsters with activated platelets
prepared from rats, and the other mAbs were raised against
recombinant P-selectin-IgG chimeric protein [14]. Native P-
selectin consists of a lectin, an epidermal growth factor-like
domain, and nine short consensus repeats; the recombinant P-
selectin-IgG protein lacks eight of the short consensus repeats.
Fig. 4. Time dependency of the plasma P-selectin levels and MPO activities in the LPS-induced rat lung injury model. Plasma and lung lysates were prepared from
LPS-(closed triangles, SD rats; closed circles, Wistar rats) or saline-(open triangles, SD rats; open circles, Wistar rats) treated rats at the indicated time points, and the
soluble P-selectin concentration (A) and MPO activity (B), respectively, were measured as described in Materials and methods. The horizontal bar indicates the mean
value for each group (solid lines, LPS-treated SD rats; dotted line, LPS-treated Wistar rats). *P<0.05, **P<0.005, and ***P<0.001, versus saline-treated mice. (C)
Correlation between P-selectin concentration and MPO activity (from zero to 24 h). The coefficients of correlation between the two parameters for SD and Wistar rats
were r=0.996 and r=0.859, respectively. (D–G) Lung histology. Lungs were obtained fromWistar (D and E) or SD (F and G) rats 4 h after the administration of saline
(D and F) or LPS (E and G). The tissue sections were stained with hematoxylin–eosin as described in Materials and methods.
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protein and its fusion with the Fc region of IgG may generate
steric distortions that affect its immunogenicity.
The ELISA reported here is sensitive enough to quantify
physiological concentrations of plasma P-selectin after the
induction of inflammation (Table 1 and Fig. 4). Although
Misugi et al. [20] developed a non-sandwich ELISA to detect
rat soluble P-selectin, their assay might not have been accurate
enough to measure the physiological concentration of soluble P-
selectin in plasma, because it used only anti-human P-selectin
polyclonal antibody. In contrast, our sandwich ELISA system
allows the accurate measurement of soluble P-selectin in
plasma.Using the newly developed ELISA, we determined the
plasma P-selectin levels during acute lung injury in the rat. The
soluble P-selectin levels correlated well with the extent of
inflammation, suggesting that measuring P-selectin levels in
plasma could be clinically informative. The level of soluble P-
selectin in plasma increased in all the rat strains examined,
although the amount differed among the strains. In the CVF-
injected Long Evans rats, the plasma P-selectin level increased
to approximately 800 ng/ml 30 min after injection (Table 1).
The increase in plasma P-selectin in Wistar and SD rats was also
detectable using our ELISA, although the increase was smaller
than in the Long Evans rats. In the LPS-injected SD rats, the
plasma P-selectin level increased 4 h after the injection, and
Table 2
Total protein and cytokines in BAL fluid collected from the lungs after challenge
with LPS a
Wistar rat SD rat
Saline LPS Saline LPS
Protein (mg/ml) 0.21±0.02 1.18±0.52 0.50±0.03 2.85±0.68
TNF-α (pg/ml) 912±29.4 2680±201 798±141 6900±189
IL-1β (pg/ml) NDb 440±16.9 NDb 730±16.3
Data are the mean±SEM of three experiments for each parameter.
a Lungs from rats were obtained 4 h after the administration of saline or LPS.
Total protein was measured by ultra-violet spectrometry. TNF-α and IL-1β
levels in the lungs were measured by ELISA.
b ND, not detectable.
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which was higher than that observed in Wistar rats (Fig. 4A).
Considering the previous report that upregulation of P-selectin
in the inflamed sites reached a maximum between 4 and 8 h
after LPS administration [21] and our finding that the soluble P-
selectin levels gradually increased thereafter reaching a
maximum at 24 h after LPS administration, it is most likely
that soluble P-selectin in plasma is derived from the sites of
inflammation. Consistent with the notions above, histological
examination indicated that relatively a larger number of
leukocyte extravasation was observed in SD rats than in Wistar
rats 4 h after LPS administration (Fig. 4D to G). In addition,
only 25 out of 52 SD rats survived 24 h after LPS
administration, whereas 24 out of 24 Wistar rats survived at
the same time point after LPS administration (unpublished
observation). In accordance with these findings, total protein
and proinflammatory cytokine concentrations in the BAL fluids
increased more significantly in SD rats than in Wistar rats
(Table 2). The differences in the increase of plasma P-selectin
levels and P-selectin-dependent lung injury may be owing to
differences in the genetic backgrounds of these rats.
In normal, healthy humans, the plasma contains low levels of
soluble P-selectin (30–60 ng/ml) [22]. In patients with vascular
disorders such as hypertension, [23] hypercholesterol anemia
[24], and unstable angina [25], levels of soluble P-selectin
ranging from 120 to 200 ng/ml, with extreme values up to
1000 ng/ml, have been reported. Soluble P-selectin may also
serve as a clinical biomarker of these diseases.
Aside from the possible clinical usefulness of this finding,
however, the functional role of soluble P-selectin per se is not
clear. In the CVF model of lung injury, rat lung inflammation is
inhibited by treatment with soluble P-selectin-IgG [26] or anti-P-
selectin mAb [27]. In addition, in the LPS model of lung injury,
rat lung inflammation is inhibited by treatment with soluble P-
selectin [28] or an anti-P-selectin mAb [29], suggesting that
soluble P-selectin might have some regulatory function exerted
by inhibiting the interaction between P-selectin and its ligand. It
is well known that P-selectin binds to P-selectin glycoprotein
ligand-1 (PSGL-1) expressed on the surface of neutrophils. We
previously reported that P-selectin also interacts with glycosa-
minoglycans that have specific structures [30,31]. Since
glycosaminoglycans are implicated in certain lung injuries
[32,33] and their biosynthesis is up-regulated during lung injury[34], glycosaminoglycans may also contribute to P-selectin-
mediated acute lung injuries. In the inflammatory setting, soluble
P-selectin secreted into the plasmamight therefore function in the
regulation of inflammatory reactions by disrupting the binding of
P-selectin to PSGL-1 and glycosaminoglycans.
In summary, we have developed a sandwich ELISA that
enables us to measure accurately the amount of soluble rat P-
selectin in plasma. By applying this system to rat lung
inflammatory models, we found that these P-selectin levels
were well correlated with the extent of lung injury. Our results
demonstrate that soluble P-selectin levels reflect lung inflamma-
tion, which is of clinical importance for detecting and preventing
severe lung injury.
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